Skip to main content
. 2018 Jul 5;13(7):e0200152. doi: 10.1371/journal.pone.0200152

Table 8. Comparisons between clinical variables grouped based on the CSI-9 severity.

Subclinical1 0–9
N = 223
Mild2
10–19 N = 240
Moderate/Severe3 20–36
N = 42
ANOVA or Chi-squared P-value Effect size
Age 52.8 (15.6) 53.1 (14.6) 46.4 (13.6) 0.02 0.15
Female (%) 129 (57.8) * 174 (72.5) 30 (71.4) 0.003 0.14
Pain duration (weeks) 15.2 (35.1) 3 24.4 (56.8) 51 (118.3) 1 0.001 0.16
Pain intensity 2.3 (1.4) 2,3 3.3 (1.7) 1,3 4.4 (1.9) 1,2 < 0.001 0.40
Pain interference 1.6 (1.5) 2,3 2.9 (2.1) 1,3 4.8 (2.4) 1,2 < 0.001 0.49
EQ-5D 0.74 (0.11) 2,3 0.70 (0.11) 1,3 0.60 (0.11) 1,2 < 0.001 0.35

Post-hoc differences between severity-level groups are indicated via superscript number.

* Male > Female

†Female > Male

Standard deviations or percentage female in parentheses